TIGERMED (03347.HK): Frontage Privatisation, Spin-Off Update

On 17 November 2026, TIGERMED (03347.HK) disclosed Frontage's audited 2025 revenue of US$256.7 million and net profit of US$6.76 million for its spin-off.

NewTimeSpace News: On 17 November 2026, Hangzhou Tigermed Consulting Co., Ltd. (stock code: 3347) issued a progress announcement on the privatisation and separation transaction of its subsidiary Frontage Holdings Corporation, disclosing the key audited financial data of Frontage for the year ended 31 December 2025 and the six months ended 30 June 2026.

According to the announcement, in US$'000, Frontage's total assets stood at 541,024, total liabilities at 192,978 and net assets at 348,046 for 2025, with operating revenue of 256,691 and net profit of 6,762; for the first half of 2026, total assets were 580,474, total liabilities 224,248 and net assets 356,226, with operating revenue of 148,190 and net profit of 6,788.

The Company cautioned that the transaction is subject to the fulfilment of pre-conditions and conditions and may or may not proceed, and advised shareholders and potential investors of the Company, the offeror or the offeree to exercise caution when dealing in the relevant securities.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.